Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for La Jolla Pharmaceutical Company (LJPC)

« Back to company index

LJPC Chatter Timeline

Stock Ticker for LJPC

Most Active Tweeters for LJPC

UserTweets
@Tickeron 7
@ZolmaxNews 4
@BlueBioNow 4
@otcdynamics 4
@Gambiste1 4

Recent Tweets for LJPC

WeekHerald @WeekHerald
La Jolla Pharmaceutical $LJPC Given Consensus Rating of “Hold” by Analysts https://t.co/PS0NkPGiiH
April 9th 2020, 2:04pm
bbnsnews @bbnsnews
La Jolla Pharmaceutical $LJPC Given Consensus Rating of “Hold” by Analysts https://t.co/3ruohe9JAV
April 9th 2020, 2:04pm
AmericanBanking @AmericanBanking
La Jolla Pharmaceutical $LJPC Given Consensus Rating of “Hold” by Analysts https://t.co/stha4i1Q08 #stocks
April 9th 2020, 2:04pm
PropThinker @PropThinker
Hypothesis: Exogenous Angiotensin II ( $LJPC Giapreza) can competitively inhibit binding to ACE-2 receptor that… https://t.co/fhmO6048zi
April 9th 2020, 9:04am
TickerReport @TickerReport
Zacks Investment Research Lowers La Jolla Pharmaceutical $LJPC to Hold https://t.co/Jpck4bjuee
April 9th 2020, 3:04am
ZolmaxNews @ZolmaxNews
La Jolla Pharmaceutical $LJPC Downgraded by Zacks Investment Research https://t.co/aktp8Vw9XW
April 9th 2020, 3:04am
EnterpriseLeade @EnterpriseLeade
Zacks Investment Research Lowers La Jolla Pharmaceutical $LJPC to Hold https://t.co/3zYw6iJ38o
April 9th 2020, 3:04am
ChartMill @ChartMill
Looking at the last year, $LJPC shows a very strong growth in Revenue. The Revenue has grown by 129.26%.… https://t.co/eTfsv7SMDE
April 9th 2020, 2:04am
Tickeron @Tickeron
$LJPC enters an Uptrend as Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and other… https://t.co/cyNbjC552H
April 9th 2020, 2:04am
ZolmaxNews @ZolmaxNews
La Jolla Pharmaceutical $LJPC and Voyager Therapeutics $VYGR Head-To-Head Contrast https://t.co/SmU6S6HdJz
April 9th 2020, 2:04am
EnterpriseLeade @EnterpriseLeade
La Jolla Pharmaceutical $LJPC and Voyager Therapeutics $VYGR Head-To-Head Contrast https://t.co/gtdc7csUo0
April 9th 2020, 1:04am
steve65614567 @steve65614567
@CNN If you are smart and want to make money - invest wisely and look hard at $LJPC- thank me very soon .... and pin this tweet
April 8th 2020, 6:04pm
ThisLincolnian @ThisLincolnian
La Jolla Pharmaceutical $LJPC Raised to Buy at Zacks Investment Research https://t.co/0S5mUQ31K6
April 8th 2020, 4:04am
EnterpriseLeade @EnterpriseLeade
La Jolla Pharmaceutical $LJPC Raised to Buy at Zacks Investment Research https://t.co/B1Ocxha5Yf
April 8th 2020, 4:04am
ZolmaxNews @ZolmaxNews
La Jolla Pharmaceutical $LJPC Raised to Buy at Zacks Investment Research https://t.co/HE0DlRRIVM
April 8th 2020, 4:04am
BlueBioNow @BlueBioNow
$LJPC watching closely ... Over $6.47 this rips 2.62 % change recently https://t.co/PvMFG51bdL
April 8th 2020, 3:04am
Tickeron @Tickeron
$LJPC in +12.8% Uptrend, growing for three consecutive days on April 6, 2020. View odds for this and other indicato… https://t.co/jO8ihTl3Uk
April 8th 2020, 2:04am
TickerSentiment @TickerSentiment
Sentiment for $LJPC out of 70 total scores; 91 % is positive and 9 % is negative. #sentiment https://t.co/Gk6Q10nFuP
April 7th 2020, 5:04pm
StockNewsNow @StockNewsNow
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Pati… https://t.co/Nm3lS06EYK
April 7th 2020, 3:04pm
MaisaCorp @MaisaCorp
$LJPC La Jolla To Provide Giapreza For Patients With Septic Shock From COVID-19 In Germany
April 7th 2020, 11:04am
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $SHI $LJPC ... https://t.co/mnYaiRHCnS
April 7th 2020, 10:04am
otcdynamics @otcdynamics
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in P https://t.co/BnE4Ewh0L7
April 7th 2020, 9:04am
PabloAl71818691 @PabloAl71818691
RT @StockNewsNow: $LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients w…
April 7th 2020, 8:04am
Tickeron @Tickeron
$LJPC in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 12, 2020. View odds for thi… https://t.co/pzS3diXBex
April 7th 2020, 3:04am
gcassidy718 @gcassidy718
$LJPC buyer at $5.93 4.66 % change recently https://t.co/8nfKq3tniR
April 6th 2020, 9:04pm
AmericanBanking @AmericanBanking
Voyager Therapeutics $VYGR & La Jolla Pharmaceutical $LJPC Head to Head Review https://t.co/BFwhgQZdJS #stocks
April 6th 2020, 9:04pm
StockNewsNow @StockNewsNow
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Pati… https://t.co/vVoGmvbrEE
April 6th 2020, 3:04pm
PabloAl71818691 @PabloAl71818691
RT @MaisaCorp: $LJPC Says Providing Giapreza In Patients With Septic Shock Due To COVID-19
April 6th 2020, 1:04pm
Briefingcom @Briefingcom
$LJPC: La Jolla Pharm to provide GIAPREZA II for named patient emergency use in patients with septic shock due to... https://t.co/9gJN5wq0fx
April 6th 2020, 10:04am
MaisaCorp @MaisaCorp
$LJPC Says Providing Giapreza In Patients With Septic Shock Due To COVID-19
April 6th 2020, 9:04am
otcdynamics @otcdynamics
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in P https://t.co/L3bwBeDh6n
April 6th 2020, 9:04am
Liborprivate @Liborprivate
$LJPC I would actually shit my pants if little $LJPC actually worked for COVID -19 , tiny market cap at 120M or so.
April 6th 2020, 8:04am
Tickeron @Tickeron
$LJPC in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 12, 2020. View odds for thi… https://t.co/ALlJuawl5W
April 6th 2020, 2:04am
Tickeron @Tickeron
$LJPC in Uptrend: price may jump up because it broke its lower Bollinger Band on March 12, 2020. View odds for this… https://t.co/47TAwibGB7
April 5th 2020, 3:04am
Gambiste1 @Gambiste1
RT @alsterbrown: 1/2 $LJPC Giapreza is a drug addressing septic shock. While it’s very important for seriously ill Covid patients today, th…
April 4th 2020, 6:04am
alsterbrown @alsterbrown
1/2 $LJPC Giapreza is a drug addressing septic shock. While it’s very important for seriously ill Covid patients to… https://t.co/D4LdyodM3v
April 3rd 2020, 10:04pm
InsiderAlertsIA @InsiderAlertsIA
$LJPC: New Insider Filing on LA JOLLA PHARMACEUTICAL CO's Chief Scientific Officer JAMES ROLKE: https://t.co/lQaXJPqORV
April 3rd 2020, 4:04pm
StockNewsNow @StockNewsNow
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Pati… https://t.co/xJWGKXbUKO
April 3rd 2020, 2:04pm
Briefingcom @Briefingcom
$LJPC: La Jolla Pharm is providing GIAPREZA for named patient emergency use in patients with septic shock due to... https://t.co/IVN2VJSZjB
April 3rd 2020, 11:04am
Liborprivate @Liborprivate
$LJPC the market cap is only 130M , so if this doubles , its still only 260M , risk/reward I’ll take . Other micro… https://t.co/Omrk8OvwRo
April 3rd 2020, 9:04am
OpenOutcrier @OpenOutcrier
$LJPC (+3.5% pre) La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency… https://t.co/zm76BKsPMd
April 3rd 2020, 8:04am
otcdynamics @otcdynamics
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in P https://t.co/hdHDJbIAww
April 3rd 2020, 8:04am
pnani456 @pnani456
RT @odibro: $LJPC to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Un…
April 3rd 2020, 8:04am
odibro @odibro
$LJPC to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to CO… https://t.co/KGcmyJTpuP
April 3rd 2020, 8:04am
James__BondOO7 @James__BondOO7
RT @TheTradeXchange: $LJPC: La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patien…
April 3rd 2020, 8:04am
InsiderAlertsIA @InsiderAlertsIA
$LJPC: New Insider Filing on LA JOLLA PHARMACEUTICAL CO's Chief Medical Officer LAKHMIR S CHAWLA: https://t.co/GFHECtjr9B
April 3rd 2020, 8:04am
TheTradeXchange @TheTradeXchange
$LJPC: La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Pat… https://t.co/apNL0zYBNB
April 3rd 2020, 8:04am
brooklyn_trader @brooklyn_trader
$LJPC La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Pati… https://t.co/ACeZU2b2wE
April 3rd 2020, 8:04am
TickerSentiment @TickerSentiment
Sentiment for $LJPC out of 88 total scores; 78 % is positive and 22 % is negative. #sentiment https://t.co/Gk6Q10nFuP
April 3rd 2020, 5:04am
Tickeron @Tickeron
$LJPC in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 12, 2020. View odds for thi… https://t.co/hMg8azyQX9
April 3rd 2020, 4:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.